VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 28, 2007) - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection CompanyTM, announced today the appointment of Dr. Annette Kleiser as Vice-President of Business Development for the Company. Dr. Kleiser, an internationally recognised pharmaceutical executive joins Allon from Epigenomics in Seattle where she held a similar position and prior to that was with Amgen, a global pharmaceutical company.
